• Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact
Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer
  • Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact

Archives

Monthly Archive for: "February, 2025"
 Message From Senior Management
 0
By Nascent Biotech
In Corporate News
Posted February 11, 2025

Message From Senior Management

601 21st Street, Suite 300 Vero Beach, FL 32960 February 11, 2025 Dear Shareholder: Our fiscal year will end March 31, 2025, and this year has proven to be challenging, yet productive.  We [...]

READ MORE
© NASCENT BIOTECH, INC. ALL RIGHTS RESERVED.